# Montelukast Sodium

NDC: 57237-212
Generic name: Montelukast Sodium
Labeler / Manufacturer: Rising Pharma Holdings, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, CHEWABLE
Routes: ORAL
Marketing started: 20120803

FDA application: ANDA202096

## Active ingredients

- MONTELUKAST SODIUM: 4 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"57237-212"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=57237-212
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=49669ac0-0bb5-4576-bed5-9e85e0d76a44